The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally disintegrating tablets to treat schizophrenia and bipolar disorder. The drugs will be jointly manufactured and distributed by Dr. Reddy's Labs (RDY +1%), Teva Pharmaceuticals (TEVA +0.9%) and Par Pharmaceuticals (PRX +1.9%).
The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally...
From other sites
at CNBC.com (Nov 6, 2014)
at CNBC.com (Jan 16, 2014)
at CNBC.com (May 14, 2013)
at CNBC.com (Oct 8, 2012)
at CNBC.com (Feb 17, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs